Customized Peptide Synthesis Market Size to Reach $390

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
41
Customized Peptide Synthesis Market Size to Reach $390 Million by 2024: P&S Intelligence

Customized Peptide Synthesis Market by Product (Reagents, Equipment [Peptide Synthesizers, Chromatography Equipment, Lyophilizers]), by Application (Commercial [Antibody Production, Drug Discovery, Enzyme Profiling], Academic Research [Disease Research, Biomarker Discovery]), by Technology (SPPS, SPS, Hybrid & Recombinant Technology), by End User (Pharmaceutical & Biotechnology Companies, CMOs & CROs, Academic & Research Institutes), by Geography (U.S., Canada, Germany, France, U.K., Italy, Spain, China, Japan, India, South Korea, Singapore, Brazil, Mexico, Israel, South Africa, Saudi Arabia) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2014–2024

NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Intelligence, customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology.

Request to get the sample pages of the report: https://www.psmarketresearch.com/market-analy...ort-sample

The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected to observe faster growth in demand, witnessing a CAGR of 6.8% during the forecast period. This growth can be attributed to the high usage of a wide range of reagents including substrates, additives, buffers, precipitation agents, and others for the purpose of peptide synthesis.

Among the various applications, commercial application is the fastest growing category in the customized peptide synthesis industry, demonstrating a CAGR of 6.9% during the forecast period. The recent advancements in chemical peptide synthesis and inclusion of modified amino acids have increased the commercial potential of customized peptides.

Based on technology, SPPS technology is predicted to be the fastest growing technology in the global market in the coming years, advancing at a CAGR of 6.9% during 2019-2024. As compared to SPS, this technology has high efficiency and throughput screening, with greater simplicity and speed for the production of peptides.

Browse report overview with 347 tables and 54 figures spread through 295 pages and detailed TOC on "Customized Peptide Synthesis Market" at: https://www.psmarketresearch.com/market-analy...sis-market

Pharmaceutical and biotechnology companies as an end-user category is predicted to witness fastest growth in the customized peptide synthesis market, registering a CAGR of 6.8% during the forecast period. This growth is mainly due to extensive research and large production of peptides by pharma and biotech companies across the globe.

During the forecast period, customized peptide synthesis market in APAC is expected to witness the fastest growth, observing a CAGR of 7.9%. The growth in the market is mainly led by the increasing use of peptides in drug discovery, low cost of raw materials, technological advancements, increasing life sciences research activities, and availability of funds for research and development.

Globally, the customized peptide synthesis market is witnessing rapid evolution with the development and launch of new peptide-based products. For instance, in September 2018, Biotage AB launched its new Alstra remote software, which enables the users to program the peptide synthesis setup offline, subsequently import peptide sequences, and then execute the synthesis on Initiator + Alstra.

Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry...sis-market

Moreover, various research institutes are actively involved in advanced research activities related to peptide synthesis. For example, in February 2017, researchers at the Massachusetts Institute of Technology (MIT) designed a machine that can rapidly produce large quantities of customized peptides. The machine can form links between amino acids in about 37 seconds and can generate peptide molecules (containing up to 60 amino acids) in less than an hour. Hence, the market is witnessing evolution on account of new product launches and advanced research.

Some of the other key players operating in the customized peptide synthesis industry are GenScript Biotech Corporation, Bachem AG, Thermo Fisher Scientific Inc., AAPPTec LLC, Advanced ChemTech, AnaSpec Inc., New England Peptide Inc., Rockland Immunochemicals Inc., INTAVIS Bioanalytical Instruments AG, and JPT Peptide Technologies GmbH.

More Reports by P&S Intelligence

Molecular Cytogenetics Market

During the forecast period, the molecular cytogenetics market is projected to witness fastest growth in APAC, at CAGR of 11.8%, mainly due to the large population in the region, untapped market and entry of global players in the industry to offer cytogenetic testing. Government initiatives such as mandatory testing, funding and training programs to the researchers are some other factors that are propelling the growth of the market in the region.

https://www.psmarketresearch.com/market-analy...ics-market

Cell Isolation Market

During the forecast period, the cell isolation market is projected to witness the fastest growth in APAC, with a CAGR of 22.1%. This is due to the increasing focus on basic and applied research by countries in the region. Besides, countries such as India and China have established research institutes promoting cell-based research. Hence, advanced healthcare infrastructure, rising adoption of innovative cell isolation products, and high demand for regenerative medicines are expected to drive the market growth in APAC in the coming years.

https://www.psmarketresearch.com/market-analy...ion-market

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn  |  Twitter  |  Google +  |  Facebook

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ingredion's Third-Quarter Stumble Sparks Legal Scrutiny

Updated Category News Views 67

Disappointment in the Ingredion Kitchen Ingredion's got that sour taste in the mouths of investors right now, and not the kind that comes from making a bad batch of sweeteners. Nah, it's the kind of sting that comes from missing the mark on Wall Street expectations in the third quarter of 2026. We're talking adjusted EPS falling short by about 19% from last year—and...

Continue Reading
Broadridge's Dividend Move: A Steady Signal

Updated Category News Views 5

Broadridge Puts a Cherry on Top with Dividend Declaration Ah, dividends—the bread and butter for those of us who savor the small victories that come with holding onto our stocks. Broadridge Financial Solutions, Inc. (NYSE: BR) just dangled a juicy carrot in front of its shareholders with their freshly declared quarterly cash dividend of $1.09 per share. Now, I've been...

Continue Reading
Suiteify Teams Up With Findity for German Launch

Updated Category News Views 25

Striking a Partnership That Makes Sense Today's deal rolls in like thunder on a quiet afternoon. Suiteify, the master of HR and business software in the DACH region, hooks up with Findity to unleash a new game-changer in Germany. They’re cooking up Suiteify Expense & Travel, and if you're in the mid-sized business space, it’s worth a pause to see how these two horses...

Continue Reading
Florida's Insurance Premiums: Why They Keep Skyrocketing

Updated Category News Views 29

What’s Driving Up These Premiums? If you’ve ever felt like your wallet gets lighter every time you pay your insurance premium, welcome to the club. It seems like the cost of insurance in Florida is like a runaway train. But don't just blame the hurricanes. Yeah, they definitely play their part, but there’s a bigger picture lurking behind those price tags. Weather...

Continue Reading
PMET Exec Shakeup as Shaakichiuwaanaan Nears Development

Updated Category News Views 38

Turning Wheels at PMET: Leadership Shuffle in Motion There's a changing of the guard over at PMET Resources as they brace for the next big steps with their Shaakichiuwaanaan Project. Ken Brinsden, their long-time President and CEO, has decided it's time to pass the baton down the line, transitioning to Executive Chair next year. This move is all about keeping a steady...

Continue Reading
Plaza Tire Opens New Location on Route 66 Corridor

Updated Category News Views 34

Expanding Horizons in the Midwest Another chapter in Plaza Tire Service's long history, folks, as it plants its flag deeper in Missouri with a new store right on the iconic Route 66. Yep, that means more options for drivers in central Missouri who've had enough of searching high and low for a reliable tire and auto service. What's New in St. Robert This latest joint isn't...

Continue Reading
Houston's Health Museum Introduces 'Sensing Sound' Exhibit

Updated Category News Views 78

Sound Takes Center Stage in Houston There's a new kind of hush in Houston and it ain't just the Texas sun setting low. Come November 21, The Health Museum throws its doors wide open with an exhibition that'll have visitors hearing sound like they've never imagined before. Now, I don't want to sound like a broken record, but this type of exhibition—the Sensing...

Continue Reading
Western Digital Faces Investigation Over Fiduciary Breaches

Updated Category News Views 314

Ringside Seat to Western Digital's Legal Turbulence If there's one thing that'll make an investor's hair stand on end, it's the whisper of fiduciary breaches. Western Digital Corporation (NASDAQ:WDC) just took a hit from Levi & Korsinsky, LLP, who've launched a full-scale investigation into potential breaches of fiduciary duties by select officers and directors. When a...

Continue Reading
Siemens Set to Acquire Lauterbach in Strategic Move

Updated Category News Views 50

Siemens Seizing New Opportunities with Lauterbach Acquisition Bam! Siemens is on the move, folks, snapping up Lauterbach to bolster its semiconductor design arsenal. Now, if you’ve got your eyes glued to innovation in chip design, like yours truly, then strap in because this merger is more than just a footnote on some dusty tech page. It's a game-changer when it comes...

Continue Reading
Jinko Solar Joins B20 Summit: Energy Forefront Focus

Updated Category News Views 80

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Continue Reading

Top 5 Most Recently Viewed Articles

Impact of Tariffs on Federal Reserve's Monetary Policy Decisions

Updated Category News Views 325

Understanding the Influence of Tariffs on Monetary Policy Jerome Powell, the Chair of the Federal Reserve, expressed that the central bank's approach to monetary policy has been significantly influenced by tariff strategies initiated by former President Donald Trump. During a recent panel discussion, he revealed insights about how these tariffs affected the central bank's...

Continue Reading
Navigating the Evolving Cystinosis Treatment Landscape

Updated Category News Views 149

Understanding the Cystinosis Treatment Landscape The cystinosis treatment landscape is experiencing significant transformation, predominantly driven by established cysteamine-based therapies. Despite the current options, there is a notable scarcity of next-generation treatments that offer curative or disease-modifying effects. Fortunately, emerging therapies are evolving...

Continue Reading
Understanding Quiet Cracking: A New Look at Employee Burnout

Updated Category News Views 185

Understanding the Phenomenon of Quiet Cracking in the Workplace Recent findings shed light on a significant issue facing employees today called "quiet cracking." This term refers to a troubling situation wherein workers meet their job responsibilities while battling burnout, emotional fatigue, and disengagement from their work. The latest survey indicates that nearly six...

Continue Reading
Tevogen Bio's Clinical Trial Shows Hope for Long COVID Treatments

Updated Category News Views 80

Tevogen Bio's Groundbreaking Clinical Trial Results Tevogen Bio has made headlines with its impressive clinical trial data regarding its innovative treatment, TVGN 489. This trial is particularly vital as it targets individuals affected by Long COVID, a condition that continues to challenge healthcare systems worldwide. The company is committed to addressing this pressing...

Continue Reading
MetaVia Initiates Fat Loss Study with DA-1726: Phase 1 Results

Updated Category News Views 163

MetaVia Launches Phase 1 Trial for Obesity Treatment MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company, has made significant strides in its journey toward transforming the approach to cardiometabolic diseases. Recently, the company announced that it has successfully dosed its first patient in a Phase 1 clinical trial dedicated to evaluating DA-1726, a...

Continue Reading